Abstract. Oxidative stress has emerged as an important pathogenic factor in the development of breast cancer. Cholesterol-rich membrane rafts or lipid rafts (LRs) are reported to play an important role in oxidative stress-induced signal transduction. NADPH oxidase-dependent reactive oxygen species (ROS) production is implicated in oxidative stress in human mammary epithelial cells. In the present study, we determined the expression and regulation of membranebound subunits by LRs in human breast cancer cells. We report that basal levels of gp91 phox and p22 phox are expressed in breast cancer cells. We demonstrate for the first time that disruption of LRs resulted in the downregulation of NADPH oxidase subunits in breast cancer cells. Cholesterol depletion by 10 mM methyl-ß-cyclodextrin (MßCD) translocated both gp91 phox and p22 phox out of LRs. Moreover, lipid raft disruption decreased NADPH oxidase activity (21.1±0.5% in MCF-7 and 28.9±1.0 in BT-549 cells), which was reversed by cholesterol repletion (95%). Therefore, the results suggest that the integrity of LRs plays an important role in the regulation of NADPH oxidase activity in breast cancer cells.
Introduction
Breast cancer is a devastating disease and is the most frequent malignant cancer diagnosed in females living in developed countries (1) . It is the second leading cause of death in women worldwide (2) and comprises 18% of all female cancers (3). The exact cause or causes of breast cancer remain unknown. Recently, oxidative stress has been implicated as one of the major causes of the pathophysiology of breast cancer (4) . However, the precise mechanism of oxidative stress being induced in human breast cancer is poorly understood.
NADPH oxidase, is a multicomponent enzyme complex that contains an integral membrane protein (flavocytochrome b 558 ) and four cytosolic protein components (p67 phox , p47 phox , p40 phox and small GTPase Rac). Flavocytochrome b 558 is a heterodimer composed of a glycosylated subunit, gp91 phox (also known as Nox2), and non-glycosylated subunit, p22 phox (5) . Recent evidence shows that gp91
phox is the major source of ROS (6) , constitutively associates with p22
phox , and forms a stable catalytic redox center (7) . In fact, p22
phox plays a crucial role in the interaction of gp91 phox with cytosolic regulatory subunits via its proline-rich domain (8) . p22 phox was also reported to be involved in angiotensin II-mediated generation of ROS in rat smooth muscle cells (9) . These finding strongly suggest that both gp91 phox and p22 phox are critical components of the NADPH oxidase.
Rafts as signaling platforms in the organization of components in membrane-directed intracellular signaling is widely accepted (10) . Lipid rafts are dynamic, detergent-resistant plasma membrane microdomains that are highly enriched in cholesterol and sphingolipids, which have been attributed to function as redox signaling platforms (10) . Recently, it has been reported that membrane-bound components of NADPH oxidase are present in LRs, and cytoplasmic components are recruited to raft-associated subunits upon activation and reconstitute the active complex presumably via protein-protein interactions (11) . Moreover, distribution and regulation of gp91 phox and its regulatory subunits by LRs were also reported in murine microglial, bovine aortic endothelial and bovine coronary arterial endothelial cells (12) . However, there are no such studies in breast cancer cells. Cholesterol depletion causes the disorganization of lipid raft microdomains and also the dissociation of raft-bound proteins (13) . Cholesterol sequestering agents, like filipin, nystatin or methyl-ß-cyclodextrin (MßCD), remove cholesterol and cause disruption of lipid rafts (14) . MßCD is a strictly surface acting agent and can selectively and rapidly remove cholesterol from the raft region of plasma membrane (15) . It has been widely used in studying the effects of cholesterol depletion on lipid raft assembly (16) . Moreover, MßCD has been reported to possess free radical scavenging activity and to protect against oxidative stress caused by addition of hydrogen peroxide (17) .
Therefore, in the present study, we are particularly interested in evaluating the existence of a functional NADPH oxidase system in breast cancer cells and its regulation by lipid rafts. We show here that both gp91 phox and p22 phox are localized with lipid rafts and lipid raft disruption using
MßCD decreases ROS production in a gp91
phox -and p22 phoxdependent manner. These observations highlight the fact that lipid raft-associated NADPH oxidases are potentially important therapeutic targets in breast cancer.
Materials and methods
Cell antibodies and reagents. An LR disruptor, methyl-ß-cyclodextrin (MßCD), and an antioxidant, N-Acetyl cysteine (NAC), were purchased from Sigma (St. Louis, MO). Antigp91 phox , p22 phox , flotillin-2 and caveolin-1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Secondary antibodies were also purchased from Santa Cruz Biotechnology.
Detection of reactive oxygen species. 2,7-dichlorofluorescein diacetate (DCFH-DA; Sigma) was used to detect total ROS in MCF-7 and BT-549 cells after treatment with 10 mM MßCD and 20 mM NAC for 1 h. After treatment, cells were incubated at 37˚C for 30 min in serum-free medium containing 20 mM DCFH-DA. Then, cells were trypsinized, resuspended in PBS and fluorescence was quantified by spectrofluorimetry (Fluorskam Ascent FL, Milford, MA) using an excitation wavelength of 480 nm and an emission wavelength of 455 nm. The results are presented as the ratio of the fluorescence of treated samples to that of control samples.
Determination of NADPH oxidase activity. The effect of MßCD on NADPH oxidase activity was determined using dihydroethidium (DHE) to measure superoxide production. Briefly, cells were grown to 80% confluence, treated with 10 mM MßCD and 20 mM NAC for 1 h and then loaded with 10 μM DHE for 40 min. Cells were washed and observed with fluorescence microscopy (Olympus TH4-100, Japan).
Amplex red cholesterol assay. Amplex red cholesterol assay was carried out to determine amount of cholesterol extracted from untreated or MßCD-treated breast cancer cells as per manufacturer's instructions (Sigma). Briefly, MCF-7 and BT-549 cells were incubated at 37˚C with different concentrations of MßCD in DMEM medium for 6 and 24 h. Cholesterol was extracted from the cell lysate by adding 200 μl of chloroform and 200 μl of methanol to 50 μl of sonicated lysate. The bottom cholesterol layer was collected and evaporated under a vacuum. The residual cholesterol was dissolved in 50 μl of ethanol, incubated with Amplex Red reagent for 30 min and fluorescence intensity was measured in a spectrofluorometer using an excitation wavelength in the range of 530-560 nm and emission wavelength of 590 nm. The percentage of reduction of cholesterol was calculated by comparing the fluorescence value of treated and untreated cells.
BrdU cell proliferation assay. BrdU cell proliferation assay was carried out to determine the cytotoxic effect of MßCD on MCF-7 and BT-549 cells according to the manufacturer's instructions (Roche Applied Science, Branford, CT). In brief, target cells (1x10 4 ) in 96-well plates were treated with 5, 7.5 and 10 mM concentrations of MßCD for 6, 12, 24 and 48 h. BrdU labeling solution (200 μl) was added to each well and incubated for 12 h. Then cells were fixed, permeabilized and the DNA was denatured by treatment with fixative/denaturing solution. Detector horseradish peroxidase-conjugated BrdU anti-mouse antibody (100 μl) was added to each well and incubated for 1.5 h. Unbound antibody was washed with PBS, 100 μl of substrate solution was added, and cells were incubated at 37˚C for 30 min. The blue fluorescence produced was quantified using a microplate reader (BioRad Systems, Philadelphia, PA) at 370 nm (reference wavelength: 492 nm), and results were expressed as percent of inhibition of cell proliferation as compared to the controls.
Reverse transcription PCR. Total RNA was isolated from MCF-7 and BT-549 cells in all treatment conditions using TRIzol reagent (Invitrogen, Carlsbad, CA). DNase-treated RNA was used as a template for reverse transcription (RT) reaction (Invitrogen) followed by PCR analysis using primers specific for gp91 phox , p22 phox and GAPDH. The PCR conditions were as follows: 94˚C for 5 min, followed by 35 cycles of 94˚C for 30 sec, 58˚C for 45 sec and 72˚C for 45 sec. GAPDH was used as an internal control (Table I) .
Western blotting. Untreated or MßCD-treated MCF-7 and BT-549 cells were harvested and homogenized in lysis buffer and processed for cell lysates. Equal amounts of cellular proteins were subjected to SDS-PAGE using appropriate percentage of acrylamide gels. After separation, proteins were transferred onto nitrocellulose membrane and blocked in 5% dry non-fat milk in PBS-T (PBS containing 0.05% Tween) for 1 h. The membrane was incubated with agitation in primary antibodies against gp91 phox and p22 phox (Santa Cruz Biotechnology) at 4˚C. To confirm equal protein loading, blots were also probed with anti-mouse GAPDH antibody. After three washes in PBS-T, the membrane was incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. After, washing bands were developed by an enhanced chemiluminescence reaction (Amersham Biosciences, Piscataway, NJ), quantified by densitometric analysis (Image J software), and expressed as a percentage of the controls.
Co-localization studies of gp91
phox and p22 phox with lipid raft markers. MCF-7 and BT-549 cells were grown to 80% Table I . Genes analyzed by reverse transcriptase-PCR.
confluence in 8-well chamber slides and left untreated or treated with 10 mM MßCD for 1 h at 37˚C. After treatment, cells were fixed with 2% paraformaldehyde and permeabilized with 0.5% Triton X-100. Then, cells were blocked with 5% BSA in PBS and incubated overnight with anti-goat gp91 phox , anti-rabbit p22 phox , anti-mouse flotillin or anti-mouse caveolin primary antibodies at 4˚C. After washing, cells were incubated with secondary anti-mouse Alexa Fluor-594 and anti-rabbit/ anti-goat Alexa Fluor-488 antibodies for 1 h at room temperature. Finally, cells were washed with PBS, mounted with anti-fading agent containing DAPI, and examined under a confocal fluorescence microscope.
Biochemical isolation of lipid rafts. MCF-7 and BT-549 cells (2-3x10
7 cells) were serum-starved overnight and then left untreated or treated with 10 mM MßCD for 24 h at 37˚C. Adherent cells were washed with PBS, lysed with extraction buffer as per manufacturer's instructions (Sigma). The cell lysates were mixed with OptiPrep ® density gradient medium (final concentration, 35% v/v), and placed at the bottom of a 12-ml ultracentrifuge tube. A discontinuous Optiprep gradient was prepared by overlaying 2 ml of 30, 25 and 20% Optiprep (prepared by diluting OptiPrep in extraction buffer) and ultracentrifuged at 100,000 x g for 4 h. Fractions were collected and analyzed by Western blotting. Fractions 2, 3, 4 were marked as raft fractions and fractions 6, 7, 8 were labeled as non-raft fractions based on the specificity to flotillin and transferrin in MCF-7 cells and caveolin and transferrin in BT-549 cells, respectively.
Cholesterol supplementation experiments. Cells were treated with 10 mM MßCD for 24 h and further incubated for 24 h with or without 2 M cholesterol MßCD complexes. Cells were harvested, homogenized in lysis buffer. Western blotting was carried out as described above. After treatment with cholesterol MßCD complexes, total ROS levels were measured as described above. Immunofluorescence assay was carried out to determine the co-localization of gp91 phox and p22
phox with raft markers after treatment with cholesterol MßCD complexes.
Data analysis. Data are presented as means ± SE of three independent experiments. Densitometric quantification was performed using Image J software for Windows. Statistical analysis was performed by means of Student's t-test; p<0.05 was considered statistically significant.
Results

Localization of lipid rafts in MCF-7 and BT-549 cells.
As an initial approach, laser scanning confocal microscopy was used to examine the localization of lipid rafts in the plasma membrane of MCF-7 and BT-549 cells (data not shown). Raft marker flotillin-2 was found in MCF-7 and caveolin-1 was found in BT-549 breast cancer cells.
Total reactive oxygen species (ROS).
Lipid rafts depend critically on cholesterol and are disrupted by cholesterol depletion. To investigate the role of LRs in the regulation of ROS generation from NADPH oxidase, we used a cholesteroldepleting agent (MßCD) to disrupt LRs. The effect of MßCD on ROS production is shown in Fig. 1A . MßCD decreased ROS by 21 and 29% in MCF-7 and BT-549, respectively. Similarly, a known antioxidant, N-acetyl cysteine, reduced ROS by 19% in MCF-7 cells and 27% in BT-549 cells. However, a known inhibitor of NADPH oxidase, diphenyleneiodonium (DPI; Sigma) decreased total ROS by 35 and 31% in MCF-7 and BT-549 cells, respectively.
NADPH oxidase activity. The DCF-DA assay is a measure of total ROS rather than a direct assay of any one particular ROS species. Therefore, an assay specific for detection of NADPH oxidase activity in terms of superoxide generation was utilized. Dihydroethidium (DHE) is a fluorescent probe specifically oxidized by superoxide and its fluorescence was used to determine the effect of MßCD on intracellular superoxide generation. MßCD decreased superoxide production as demonstrated by a decrease in ethidium fluorescence when compared to the control as well as a positive control, N-acetyl cysteine ( Fig. 1B and C) . Taken together, these results suggest that NADPH oxidase is regulated by lipid rafts.
Effect of enzyme inhibitors on generation of superoxide.
To rule out other sources of superoxide, breast cancer cells were also treated with apocynin (a specific inhibitor of NADPH oxidase), rotenone (mitochondria electron transport inhibitor), oxypurinol (xanthine oxidase inhibitor), L-NAME (nitric oxide synthase) or MßCD for 1 h and then stained with DHE. Fluorescence was measured on excitation at 488 nm and emission at 610 nm. Only MßCD and APC decreased ROS; other inhibitors failed to decrease ROS. These results suggest that NADPH oxidase is the primary source of intracellular ROS generation (Fig. 1D) .
Depletion of membrane cholesterol. Sterols play a crucial regulatory and structural role in the lateral organization of eukaryotic cell membranes. Cholesterol has been connected to the possible formation of ordered lipid domains (rafts) in mammalian cell membranes. Cholesterol and sphingomyelin are thought to be the principal components of lipid rafts in cell and model membranes (18) . To deplete MCF-7 and BT-549 cells of cholesterol to levels that affected NADPH oxidase activity, cells were treated with 5.0, 7.5 and 10 mM MßCD for 6 and 24 h. As shown in Fig. 2A and B, 10 mM MßCD removed 47.2 and 23.3% of total cholesterol in MCF-7 and BT-549 cells, respectively, in 24 h. Moreover, extraction of cholesterol in both MCF-7 and BT549 cells occurred in a concentration-dependent manner, which is similar to other reports (19) .
Cytotoxic effect of MßCD on MCF-7 and BT-549 cells.
MßCD is widely used to disrupt lipid rafts and is the focus of drug development. The toxicity is reported to be varied and dependent on the cell type and the concentration used. We evaluated the potential toxicity of MßCD using the BrdU cell proliferation assay. We first exposed MCF-7 and BT-549 cells to various concentrations of MßCD for 6, 12, 24 and 48 h to determine the dose response. After 24 h, 10 mM MßCD caused 22% growth inhibition in MCF-7 cells and 29% in BT-549 cells (Fig. 2C and D) . However, at 48 h, there was a significant loss of cell viability in both MCF-7 (34%) and BT-549 (42%) cells.
Expression of NADPH oxidase in MCF-7 and BT-549 cells.
To determine whether NADPH oxidase is regulated by lipid rafts, we examined the expression of membrane-bound subunits of NADPH oxidase at the mRNA level after treatment with 10 mM MßCD for 6 and 24 h. MCF-7 and BT-549 cells were treated with apocynin (a specific inhibitor of NADPH oxidase), rotenone (mitochondria electron transport inhibitor), oxypurinol (xanthine oxidase inhibitor) L-NAME (nitric oxide synthase) or MßCD for 1 h and stained with DHE. Fluorescence was measured on excitation at 488 nm and emission at 610 nm. The values were expressed as mean ± SD for three independent experiments (Apc, apocynin; Rtn, rotenone; Opl, oxypurinol).
was significantly downregulated by 85% in MCF-7 cells and 80% in BT-549 cells after treatment with MßCD for 24 h (Fig. 3D-F) . We also attempted to confirm the regulation of NADPH oxidase subunits by lipid rafts in MCF-7 and BT-549 cells using an independent line of evidence. To this end, we screened membrane-soluble homogenate (25,000 x g supernatant) obtained at 6 and 24 h after treatment with MßCD. We performed Western blot analysis using gp91 phox and p22 phox polyclonal antibodies. The expression of gp91 phox and p22 phox is depicted in Fig. 4A-D . The results show that gp91 phox significantly decreased in MCF-7 (61%) and BT-549 (78%) cells (Fig. 4E) whereas p22 phox significantly decreased in MCF-7 (90%) and BT-549 (95%) cells (Fig. 4F) .
Association of lipid rafts with gp91
phox and p22 phox in MCF-7 and BT-549 cells. The size of lipid rafts is <100 nm (20) , which falls below the resolution of light microscopic techniques. However, antibody mediated co-localization of cell surface antigen has previously been used to demonstrate raft association (18) . Under resting conditions (untreated), there were a number of yellow areas (e.g., dots or patches) resulting from the merging of two sequentially scanned images obtained at different wavelengths. These yellow patches are considered evidence of co-localization of LR and gp91 phox in MCF-7 and BT-549 cells. When the cells were pretreated with MßCD, we no longer observed the yellow patches ( Fig. 5A and B) . We also carried out similar experiments using a p22 phox antibody; we observed a similar distribution pattern to gp91 MßCD decreased NADPH oxidase activity and expression at both protein and mRNA levels. To assess whether the effect of MßCD on NADPH oxidase is permanent or reversible, exogenous cholesterol was used to replenish the reduced level of lipid rafts-associated cholesterol in MßCD-treated breast cancer cells. In this experiment, both MCF-7 and BT-549 cells were pretreated with MßCD for 24 h and then supplemented with or without MßCD cholesterol complex for 24 h. We used laser-scanned confocal microscopy to analyze the expression of gp91 phox and p22 phox in cells treated with MßCD and cholesterol, MßCD alone and no treatment. The images demonstrated that yellow dots or patches were present in untreated cells, but absent in MßCD-treated cells. Notably, these patches returned in MCF-7 and BT-549 cells when MßCD treatment was followed by cholesterol supplementation ( Fig. 5E-H ). Lysates were prepared and subjected to immunoblotting analysis. Expression of gp91 phox and p22 phox was reversed by 90-95% with cholesterol supplementation (Fig. 5I and J) . These results indicate that the gp91 phox and p22 phox subunits of NADPH oxidase mainly associate with lipid rafts.
Biochemical analysis of lipid raft fractions for gp91
phox and p22 phox . In previous experiments, gp91 phox and p22 phox were co-localized with lipid raft markers flotillin or caveolin in MCF-7 and BT-549 cells. To confirm the effect of LRs on NADPH oxidase, LR fractions were isolated from the plasma membrane after treatment with MßCD. As shown in Fig. 6A and B, Western blot analysis showed positive expression of raft marker flotillin-2 and caveolin-1 in fractions 2-4 of MCF-7 and BT-549 cells, respectively; we designated these as the raft fractions (11). gp91 phox was only distributed in the raft position, and after treatment with MßCD, it was shifted to non-raft position in both MCF-7 and BT-549 cells (Fig. 6C) .
In contrast, p22 phox was distributed in both raft and non-raft position; however, after MßCD treatment, it shifted to the non-raft position (Fig. 6D) . These results confirm that both gp91 phox and p22 phox are localized to the lipid rafts.
Discussion
Oxidative damage has been implicated in the aging process and in numerous clinical conditions, including cancer (21). Many epithelial cancers like breast, colon and neck cancers exhibit increased ROS production as compared to normal epithelial cells (22) . The levels of intracellular ROS in cells ultimately affect cell cycle progression and cell proliferation. The first Nox protein identified was Nox2 in the 1980s, originally called gp91 phox . It is usually found in membranes with its signaling partner, p22
phox . Together, they form the complex known as flavocytochrome b 558 . gp91 phox belongs to the NADPH oxidase (Nox) family and contains the entire electron-transporting apparatus (23) . The association of p22 phox with gp91 phox may also be essential for regulation of electron transfer in redox cycle (24) , stabilization of gp91 phox (25) and recruitment of cytosolic subunits (26) . Despite the enormous progress in NADPH oxidase research, much remains to be understood regarding molecular mechanisms responsible for regulation of gp91 phox and p22 phox and their compartmentalization especially in cancer cells.
For the first time, this study shows basal expression and association of lipid rafts with gp91 phox and p22 phox , the redox center components of phagocyte NADPH oxidase in breast cancer cells. We have characterized the expression of these subunits and their co-localization with lipid rafts using several independent approaches, including enzymatic assays, immunological assays and RT-PCR analysis. The novel findings of the present study are as follows: i) Expression of phox and p22 phox membrane-bound subunits of NADPH oxidase; ii) association of gp91 phox and p22 phox subunits with lipid rafts; and iii) regulation of gp91 phox and p22 phox subunits by cholesterol levels of membrane in MCF-7 (an estrogen receptor-positive breast cancer cell line) and BT-549 (an estrogen receptor-negative breast cancer cell line).
Breast cancer cells are reported to contain elevated levels of lipid rafts and to be more sensitive to cholesterol depletioninduced cell death (27) . In the present study, we observed the lipid raft markers flotillin-1 in MCF-7 cells and caveolin-2 in BT549 cells. These results confirm previous reports of flotillin-2 in MCF-7 (28) and caveolin in BT-549 breast cancer cells (29) . In the basal state, low levels of NADPH oxidases are constitutively expressed in cells (30) ; this expression can be enhanced by stimulators. The current studies show that Nox-dependent ROS production is differentially regulated in lipid rafts and non-lipid rafts (11) . These studies also suggest inherent differences in the regulation of NADPH oxidase activity by lipid rafts, but the causes of such inherent differences remain to be discovered. In the present study, we demonstrate that the lipid raft-associated NADPH oxidase is critical for the formation of ROS in breast cancer cells. Our studies show that cholesterol depletion by MßCD caused a decrease in total ROS production as well as NADPH oxidase activity in MCF-7 and BT-549 cells. Similarly, extraction of cholesterol by MßCD inhibited superoxide generation in HL-60 cells (19) . However, cholesterol depletion increased the ROS production in hRPT and HEK-293 cells (12) . MßCD, a known disruptor of lipid rafts, also reported to rescue ROS levels in yeast and protect against oxidative stress (17) . This study supports the notion that cholesterol, an important component of lipid rafts, affects basal oxidase activity and ROS production by means of stimulation or inhibition.
We also demonstrate that NADPH oxidase is the main source of ROS in MCF-7 and BT-549 cells as rotenone (mitochondrial electron transport inhibitor), oxypurinol (xanthine oxidase inhibitor) and L-NAME (nitric oxide synthase inhibitor) failed to inhibit ROS production as compared to MßCD. Recently, isoforms of NADPH oxidase (DUOXs) are also reported as the major source of ROS in epithelial breast cancer cells (31) .
Cholesterol contents of cell membranes are tightly regulated. Cholesterol accumulation has been reported in various solid tumors including prostate cancer (32) . Its metabolism is dysregulated in many malignancies (33, 34) , thereby indicating a possible role of cholesterol in cancer development. One of the important findings in the present study is that treatment with 10 mM MßCD for 24 h reduced membrane cholesterol levels (47.2% in MCF-7 cells and 23.3% in BT-549 cells). However, it depleted cholesterol by 60% in mast cells (35) and 20% in arterial rings (36) in 1 h. In addition to lipid disruption, depletion of membrane cholesterol by MßCD causes increased uterine activity in obese women (37) and also plays an important role in cardiovascular diseases (38) .
Cyclodextrins, especially methylated-ß-cyclodextrins, offer several advantages for drug delivery and lipid raft disruption. However, the toxic effect of MßCD on cell viability is dependent on the final concentration and the particular cell type used. The present study revealed that MßCD affected cell viability in a concentration-dependent manner, with a significant loss of viability at 48 h. In contrast, no loss of viability was observed for up to 144 h in human skin fibroblasts (38, 39) .
NADPH oxidase-dependent superoxide generation has been found to be abnormally enhanced in several chronic diseases (40) . However, extensive analysis of the expression of NADPH oxidase subunits, particularly two critical subunits gp91 phox and p22 phox , in breast cancer cells and their regulation in lipid rafts has not yet been reported. Thus, in screening for the expression of the membrane-bound NADPH oxidase subunits gp91
phox and p22 phox in MCF-7 and BT-549 breast cancer cells, we observed that both of these subunits could be detected by RT-PCR, but their expression was significantly (p<0.05) reduced in MßCD-treated cells as compared to untreated cells. The percentage of inhibition of gp91 phox and p22 phox was different in both cells lines. To our knowledge, this is the first investigation of mRNA expression of ROSgenerating Nox2 and localization in lipid rafts in breast cancer.
Nox2-and Nox4-based NADPH oxidases appear to be the predominant contributors to oxidative stress (38) . The gp91 phox system in phagocytes has an apparent 91-kDa molecular mass due to extensive glycosylation. However, the antibody used in the present study, which is selective for unique amino acid sequences on this subunit [anti-goat gp91
phox antibody (C-15), Santa Cruz Biotechnology], detected protein with molecular mass of 55 kDa both in MCF-7 and BT-549 cells. This 55-kDa protein product may be due to lack of extensive glycosylation (41) . It is likely that the protein subunits observed with the gp91 phox antibody originate from differences in glycosylation and perhaps regulation through other forms of covalent bond modification (42) . In other studies, antibodies for gp91 phox have detected 65, 75 and 110 kDa proteins (43) (44) (45) . Elevated levels of lipid rafts have been reported in breast cancer cells (27) . Recently, expression of Nox isoforms (Nox1-5) has been reported in some breast cancer cell lines, including MCF-7 (46) . Therefore, we speculated that there is an association between lipid rafts and NADPH oxidases in breast cancer cells. In the present study, one notable result is that although both gp91 phox and p22 phox proteins were downregulated, p22
phox was much more significantly downregulated than gp91
phox by MßCD in both MCF-7 and BT-549 cells. These results indicate that p22 phox regulates catalytic function of gp91 phox , possibly via interaction with lipid rafts. In addition, the key role of p22 phox in stabilizing catalytic subunits (47) and in the interaction of cytosolic organizer protein p47 phox (8) has been reported.
In the present study, we also investigated the intracellular localization of gp91 phox and p22 phox in MCF-7 and BT-549 cells. Our data indicate that, gp91
phox was co-localized with the lipid raft marker flotillin-2 on the cell surface of MCF-7 cells as well as caveolin-1 on the cell surface of BT-549 cells. Moreover, co-localization of gp91 phox with the lipid raft marker GM1 in HL-60 cells has been reported (19) . In addition, colocalization of both gp91 phox and p22 phox with lipid rafts has been demonstrated in hRPT cells (12) .
Several studies have shown that lipid rafts serve as platforms to store proteins and to keep some proteins in the active or in the inactive state (48) . In fact, several lines of study have demonstrated that the depletion of cholesterol from the plasma membrane causes disruption of rafts/caveolae and release of raft/caveola constituents into a non-raft/caveola membrane, which renders them non-functional (49, 50) . Some NADPH oxidases and their components are localized to lipid rafts for activation. To provide direct evidence, we isolated lipid rafts fractions and analyzed them using Western blotting. Under basal conditions, both gp91 phox and p22 phox are located in LRs. Disruption of lipid rafts with MßCD allowed the NADPH oxidase subunits (gp91 phox and p22 phox ) to move from raft to non-raft positions in the membrane; this finding is similar to previous reports (51, 52) . These results suggest that LRs play a pivotal role in the regulation of NADPH oxidase.
To confirm the effect of cholesterol depletion by MßCD on NADPH activity and expression, we supplemented MßCD treatment with cholesterol. This treatment almost completely reversed the inhibitory effect of MßCD in MCF-7 and BT-549 breast cancer cells. In another study, supplementation of cholesterol reversed the inhibitory effect on lipid raft-associated, EGF-induced chemotaxis in human breast cancer cells (53) .
In summary, we show for the first time that NADPH oxidase is regulated through the distribution of its catalytic subunit, gp91
phox , and its stabilizing subunit, p22 phox , in membrane microdomains. Disruption of the lipid rafts decreases NADPH oxidase and ROS production. Therefore, the integrity of lipid rafts plays an important role in regulating NADPH oxidase in breast cancer cells. Further experiments are under progress towards determination of the functional importance of localized ROS production and the targeting mechanism of NADPH oxidase in breast cancer cells.
